Defining the Role of Oral Pathway Inhibitors as Targeted Therapeutics in Arteriovenous Malformation Care

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Biomedicines

Topics

Biology

Bioinformatics

Medicine

Pediatrics

Surgery

Show all topics

DOI

10.3390/biomedicines12061289

License

CC-BY

Other Formats

PDF